Latest Cannabinoids News

Page 7 of 7

InhaleRx Secures $38.5M to Accelerate Inhaled Drug Trials for Cancer Pain and Panic Disorder

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

Ada Torres

24 Jan 2025

Browse the archive

Full archive

Oct 2026 Sept 2026 Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026